2015 annual financial data
ImmunityBio 2015 Operating cash flow
Direct answer
Operating cash flow was -25,305,000 USD.
Operating income was -238,876,000 USD and net income was -236,876,000 USD.
Operating cash flow was -25,305,000 USD.
Get free ImmunityBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 236,000 USD
- Operating income
- -238,876,000 USD
- Net income
- -236,876,000 USD
- Operating cash flow
- -25,305,000 USD